This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tang, X. X. Articles by Ikegaki, N. Search for Related Content PubMed PubMed Citation Articles by Tang, X. X. Articles by Ikegaki, N.

High-Level Expression of EPHB6, EFNB2, and EFNB3 Is Associated with Low Tumor Stage and High TrkA Expression in Human Neuroblastomas¹

Divisions of Oncology [X. X. T., A. E. E., G. M. B., N. I.] and Biostatistics [H. Z., A. C.], The Children’s Hospital of Philadelphia, Abramson Research Center, Philadelphia, Pennsylvania 19104-4318; University of Florida, Pediatric Oncology Group, Statistical Office, Gainesville, Florida 32601 [W. L.]; and Department of Pediatrics, Northwestern University and Children’s Memorial Hospital, Chicago, Illinois 60614-3394 [S. L. C.]

Neuroblastoma (NB) is a common pediatric tumor of neural crest origin that is biologically and clinically heterogeneous. EPH family receptor tyrosine kinases and ephrin ligands play fundamental roles in neurodevelopmental processes. Recently, we found that NB cell lines expressed several EPHB and EFNB transcripts, which encode EPHB subgroup receptors and ephrin-B subgroup ligands, respectively. To explore the role of EPHB receptors and ephrin-B ligands in the biology of NB, we examined the expression of EPHB and EFNB transcripts in 47 primary NB specimens. Multiple EPHB and EFNB transcripts were expressed in all of the NB tumors examined, suggesting the involvement of these transcripts in modulating the biological behavior of NB. Higher levels of EPHB6, EFNB2, and EFNB3 expression were found in low-stage tumors (stage 1, 2, and 4S) than in advanced-stage tumors (stage 3 and 4; P = 0.0013, P = 0.0048, and P = 0.027, respectively). Expression of TrkA, a well-established prognostic marker of favorable NB, was positively correlated with EPHB6, EFNB2, and EFNB3 expression (P < 0.0001, P = 0.0019, and P = 0.0001, respectively). MYCN-amplified tumors expressed lower levels of EPHB6, EFNB2, EFNB3, and TrkA transcripts compared to nonamplified tumors (P = 0.0006, P = 0.0023, P = 0.0048, and P = 0.0001, respectively). These data suggest that high-level expression of EPHB6, EFNB2, and EFNB3 is associated with favorable NB and that low-level expression of EPHB6, EFNB2, and EFNB3 correlates with aggressive MYCN-amplified NB. Thus, EPHB6, EFNB2, and EFNB3 may have biological relevance in NB. Further investigation on the biology of these genes may help provide insight into the treatment of NB.

This article has been cited by other articles:

				S. Alam, J Fujimoto, I Jahan, E Sato, and T Tamaya Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers Ann. Onc., March 1, 2007; 18(3): 485 - 490. [Abstract] [Full Text] [PDF]

				U. K. Sinha, K. Mazhar, S. B. Chinn, V. K. Dhillon, L. Liu, R. Masood, D. H. Rice, and P. S. Gill The Association Between Elevated EphB4 Expression, Smoking Status, and Advanced-Stage Disease in Patients With Head and Neck Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg, October 1, 2006; 132(10): 1053 - 1059. [Abstract] [Full Text] [PDF]

				M. Nakada, K. L. Drake, S. Nakada, J. A. Niska, and M. E. Berens Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1. Cancer Res., September 1, 2006; 66(17): 8492 - 8500. [Abstract] [Full Text] [PDF]

				H. Guo, H. Miao, L. Gerber, J. Singh, M. F. Denning, A. C. Gilliam, and B. Wang Disruption of EphA2 Receptor Tyrosine Kinase Leads to Increased Susceptibility to Carcinogenesis in Mouse Skin. Cancer Res., July 15, 2006; 66(14): 7050 - 7058. [Abstract] [Full Text] [PDF]

				X. X. Tang, H. Zhao, B. Kung, D. Y. Kim, S. L. Hicks, S. L. Cohn, N.-K. Cheung, R. C. Seeger, A. E. Evans, and N. Ikegaki The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma. Cancer Res., March 1, 2006; 66(5): 2826 - 2833. [Abstract] [Full Text] [PDF]

				J. Holmberg, A. Armulik, K.-A. Senti, K. Edoff, K. Spalding, S. Momma, R. Cassidy, J. G. Flanagan, and J. Frisen Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis Genes & Dev., February 15, 2005; 19(4): 462 - 471. [Abstract] [Full Text] [PDF]

				L. McArdle, M. McDermott, R. Purcell, D. Grehan, A. O'Meara, F. Breatnach, D. Catchpoole, A. C. Culhane, I. Jeffery, W. M. Gallagher, et al. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q Carcinogenesis, September 1, 2004; 25(9): 1599 - 1609. [Abstract] [Full Text] [PDF]

				X. X. Tang, M. E. Robinson, J. S. Riceberg, D. Y. Kim, B. Kung, T. B. Titus, S. Hayashi, A. W. Flake, D. Carpentieri, and N. Ikegaki Favorable Neuroblastoma Genes and Molecular Therapeutics of Neuroblastoma Clin. Cancer Res., September 1, 2004; 10(17): 5837 - 5844. [Abstract] [Full Text] [PDF]

				M. Nakada, J. A. Niska, H. Miyamori, W. S. McDonough, J. Wu, H. Sato, and M. E. Berens The Phosphorylation of EphB2 Receptor Regulates Migration and Invasion of Human Glioma Cells Cancer Res., May 1, 2004; 64(9): 3179 - 3185. [Abstract] [Full Text] [PDF]

				W. Mao, E. Luis, S. Ross, J. Silva, C. Tan, C. Crowley, C. Chui, G. Franz, P. Senter, H. Koeppen, et al. EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer Cancer Res., February 1, 2004; 64(3): 781 - 788. [Abstract] [Full Text] [PDF]

				M. A. Grotzer, M. D. Hogarty, A. J. Janss, X. Liu, H. Zhao, A. Eggert, L. N. Sutton, L. B. Rorke, G. M. Brodeur, and P. C. Phillips MYC Messenger RNA Expression Predicts Survival Outcome in Childhood Primitive Neuroectodermal Tumor/Medulloblastoma Clin. Cancer Res., August 1, 2001; 7(8): 2425 - 2433. [Abstract] [Full Text] [PDF]

				X. X. Tang, H. Zhao, M. E. Robinson, B. Cohen, A. Cnaan, W. London, S. L. Cohn, N.-K. V. Cheung, G. M. Brodeur, A. E. Evans, et al. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma PNAS, September 26, 2000; 97(20): 10936 - 10941. [Abstract] [Full Text] [PDF]